ID
12421
Beskrivning
Evaluation of the Long-term Persistence of Hepatitis A Antibodies in Healthy Adults Who Were Vaccinated 21-25 Years Earlier With GlaxoSmithKline (GSK) Biologicals' Hepatitis A Vaccine, Havrix®; ODM derived from: https://clinicaltrials.gov/show/NCT02124785
Länk
https://clinicaltrials.gov/show/NCT02124785
Nyckelord
Versioner (2)
- 2015-11-17 2015-11-17 -
- 2015-11-17 2015-11-17 - Julian Varghese
Uppladdad den
17 november 2015
DOI
För en begäran logga in.
Licens
Creative Commons BY-NC 3.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility Hepatitis A NCT02124785
Eligibility Hepatitis A NCT02124785
- StudyEvent: Eligibility
Beskrivning
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Beskrivning
History of hepatitis
Datatyp
boolean
Alias
- UMLS CUI [1]
- C1997459
Beskrivning
Hepatitis A Vaccines
Datatyp
boolean
Alias
- UMLS CUI [1]
- C0170300
Beskrivning
Immunosuppressive or immunodeficient condition
Datatyp
boolean
Alias
- UMLS CUI [1]
- C0021079
- UMLS CUI [2]
- C0021051
Beskrivning
Hepatitis A immunoglobulin
Datatyp
boolean
Alias
- UMLS CUI [1]
- C3652495
Beskrivning
Administration of immunosuppressants
Datatyp
boolean
Alias
- UMLS CUI [1]
- C0021081
- UMLS CUI [2]
- C0279021
Beskrivning
Administration of long-acting immune-modifying drugs (e.g. infliximab)
Datatyp
boolean
Alias
- UMLS CUI [1]
- C1134703
Beskrivning
Study Subject Participation Status
Datatyp
boolean
Alias
- UMLS CUI [1]
- C2348568
Similar models
Eligibility Hepatitis A NCT02124785
- StudyEvent: Eligibility
C0021051 (UMLS CUI [2])
C0279021 (UMLS CUI [2])